Comparative efficacies of albendazole and the Chinese herbal medicine long-dan-xie-gan-tan, used alone or in combination, in the treatment of experimental eosinophilic meningitis induced by Angiostrongylus cantonensis

Annals of Tropical Medicine and Parasitology

Volumn 102, Issue 2, 2008, Pages 143-150

  Lai, S C ^a   Chen, K M ^a   Chang, Y H ^a   Lee, H H ^a  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; ALBUMIN; GELATINASE B; LONG DAN XIE GAN TAN; PLANT EXTRACT; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

ANGIOSTRONGYLUS CANTONENSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BAGG ALBINO MOUSE; CEREBROSPINAL FLUID ANALYSIS; CHINESE HERB; CHINESE MEDICINE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRUG EFFICACY; ENZYME ASSAY; EOSINOPHIL COUNT; HISTOPATHOLOGY; MALE; MENINGITIS; MONOTHERAPY; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION;

ALBENDAZOLE; ANGIOSTRONGYLUS CANTONENSIS; ANIMALS; ANTHELMINTICS; DRUG THERAPY, COMBINATION; DRUGS, CHINESE HERBAL; EOSINOPHILIA; LARVA; MALE; MATRIX METALLOPROTEINASE 9; MENINGOENCEPHALITIS; MICE; MICE, INBRED BALB C; MODELS, ANIMAL; STRONGYLIDA INFECTIONS; TREATMENT OUTCOME;

ANGIOSTRONGYLUS CANTONENSIS; MUS; RATTUS;

EID: 44449094713     PISSN: 00034983     EISSN: None     Source Type: Journal    
DOI: 10.1179/136485908X252304     Document Type: Article

References (26)

1. Alicata, J. E. (1965). Biology and distribution of the rat lungworm, Angiostrongylus cantonensis, and its relationship to eosinophilic meningo-encephalitis and other neurological disorders of man and animals. Advances in Parasitology, 3, 223-248.
2. Aris, R. M., Walsh, S., Chalermskulrat, W., Hathwar, V. & Neuringer, I. P. (2002). Growth factor upregulation during obliterative bronchiolitis in the mouse model. American Journal of Respiratory and Critical Care Medicine, 166, 417-422.
3. Betsuyaku, T., Fukuda, Y., Parks, W. C., Shipley, J. M. & Senior, R. M. (2000). Gelatinase B is required for alveolar bronchiolization after intratracheal bleomycin. American Journal of Pathology, 157, 525-535.
4. Boven, L. A., Vergnolle, N., Henry, S. D., Silva, C., Imai, Y., Holden, J., Warren, K., Hollenberg, M. D. & Power, C. (2003). Up-regulation of proteinase-activated receptor 1 expression in astrocytes during HIV encephalitis. Journal of Immunology, 170, 2638-2646.
5. Busch, E., Kruger, K., Fritze, K., Allegrini, P. R., Hoehn-Berlage, M. & Hossmann, K. A. (1997). Blood-brain barrier disturbances after rt-PA treatment of thromboembolic stroke in the rat. Acta Neurochirurgica. Supplement, 70, 206-208.
6. Chang, W. S., Lee, Y. J., Lu, F. J. & Chiang, H. C. (1993). Inhibitory effects of flavonoids on xanthine oxidase. Anticancer Research, 13, 2165-2170.
7. Chen, K. M., Lee, H. H., Lu, K. H., Tseng, Y. K., Hsu, L. S., Chou, H. L. & Lai, S. C. (2004). Association of matrix metalloproteinase-9 and Purkinje cell degeneration in mouse cerebellum caused by Angiostrongylus cantonensis. International Journal for Parasitology, 34, 1147-1156.
8. Chen, K. M., Liu, J. Y., Lai, S. C., Hsu, L. S. & Lee, H. H. (2006). Association of plasminogen activators and matrix metalloproteinase-9 proteolytic cascade with blood-CNS barrier damage of angiostrongyliasis. International Journal of Experimental Pathology, 87, 113-119.
9. Chotmongkol, V., Sawanyawisuth, K. & Thavornpitak, Y. (2000). Corticosteroid treatment of eosinophilic meningitis. Clinical Infectious Diseases, 31, 660-662.
10. Chou, C. C., Pan, S. L., Teng, C. M. & Guh, J. H. (2003). Pharmacological evaluation of several major ingredients of Chinese herbal medicines in human hepatoma Hep3B cells. European Journal of Pharmaceutical Sciences, 19, 403-412.
11. Hou, R. F., Tu, W. C., Lee, H. H., Chen, K. M., Chou, H. L. & Lai, S. C. (2004). Elevation of plasminogen activators in cerebrospinal fluid of mice with eosinophilic meningitis caused by Angiostrongylus cantonensis. International Journal for Parasitology, 34, 1355-1346.
12. Jitpimolmard, S., Sawanyawisuth, K., Morakote, N., Vejjajiva, A., Puntumetakul, M., Sanchaisuriya, K., Tassaneeyakul, W., Tassaneeyakul, W. & Korwanich, N. (2007). Albendazole therapy for eosinophilic meningitis caused by Angiostrongylus cantonensis. Parasitology Research, 100, 1293-1296.
13. Kuberski, T. & Wallace, G. D. (1979). Clinical manifestations of eosinophilic meningitis due to Angiostrongylus cantonensis. Neurology, 29, 1566-1570.
14. Lai, S. C., Twu, J. J., Jiang, S. T., Hsu, J. D., Chen, K. M., Chiaing, H. C., Wang, C. J. & Lee, H. H. (2004). Induction of matrix metalloproteinase-9 in murine eosinophilic meningitis caused by Angiostrongylus cantonensis. Annals of Tropical Medicine and Parasitology, 98, 715-724.
15. Lan, K. P., Wang, C. J., Lai, S. C., Chen, K. M., Lee, S. S., Hsu, J. D. & Lee, H. H. (2004). The efficacy of therapy with albendazole in mice with parasitic meningitis caused by Angiostrongylus cantonensis. Parasitology Research, 93, 311-317.
16. Lee, H. H., Chou, H. L., Chen, K. M. & Lai, S. C. (2004). Association of matrix-metalloproteinase-9 in eosinophilic meningitis of BALB/c mice caused by Angiostrongylus cantonensis. Parasitology Research, 94, 321-328.
17. Leppert, D., Leib, S. L., Grygar, C., Miller, K. M., Schaad, U. B. & Hollander, G. A. (2000). Matrix metalloproteinase (MMP)-8 and MMP-9 in cerebrospinal fluid during bacterial meningitis: association with blood-brain barrier damage and neurological sequelae. Clinical Infectious Diseases, 31, 80-84.
18. Lin, C. C. & Shieh, D. E. (1996). The antiinflammatory activity of Scutellaria rivularis extracts and its active and its active components, baicalin, baicalein and wogonin. American Journal of Chinese Medicine, 24, 31-36.
19. Parsons, J. C. & Grieve, R. B. (1990). Effect of egg dosage and host genotype on liver trapping in murine larval toxocariasis. Journal of Parasitology, 76, 53-58.
20. Pien, F. D. & Pien, B. C. (1999). Angiostrongylus cantonensis eosinophilic meningitis. International Journal of Infectious Diseases, 3, 161-163.
21. Rosenberg, G. A., Kornfeld, M., Estrada, E., Kelley, R. O., Liotta, L. A. & Stetler-Stevenson, W. G. (1992). TIMP-2 reduces proteolytic opening of blood-brain barrier by type-IV collagenase. Brain, 576, 203-207.
22. Shimizu, I. (2000). Sho-saiko-to: Japanese herbal medicine for protection against hepatic fibrosis and carcinoma. Journal of Gastroenterology and Hepatology, 15 (Suppl.), D84-D90.
23. Tungkanak, R., Sirisinha, S. & Punyagupta, S. (1972). Serum and cerebrospinal fluid in eosinophilic meningoencephalitis: immunoglobulins and antibody to Angiostrongylus cantonensis. American Journal of Tropical Medicine and Hygiene, 21, 415-420.
24. Venkatesan, P. (1998). Albendazole. Journal of Antimicrobial Chemotherapy, 41, 145-147.
25. Winkler, F., Kastenbauer, S., Koedel, U. & Pfister, H. W. (2002). Role of the urokinase plasminogen activator system in patients with bacterial meningitis. Neurology, 59, 1350-1355.
26. Yii, C. Y. (1976). Clinical observations on eosinophilic meningitis and meningoencephalitis caused by Angiostrongylus cantonensis on Taiwan. American Journal of Tropical Medicine and Hygiene, 25, 233-249.